Ranibizumab ophthalmic for Diabetic Retinopathy User Reviews
Brand names: Lucentis, Byooviz, Cimerli, Susvimo
- Nic...
- Taken for less than 1 month
- November 27, 2019
"I believe this injection killed my 80-year-old grandmother. Two days after her injection, she had a numb tongue, was puking and weak, went to bed, and never woke up again."
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about ranibizumab ophthalmic
- Check interactions
- Compare alternatives
- Reviews (18)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
Patient resources
- Ranibizumab ophthalmic drug information
- Ranibizumab (Advanced Reading)
- Ranibizumab-eqrn (Advanced Reading)
- Ranibizumab
Other brands
Lucentis, Byooviz, Cimerli, Susvimo
Professional resources
Other brands
Lucentis, Byooviz, Cimerli, Susvimo
"I finished treatment a few months ago, and it is getting worse. It's all blurry. I went back with the specialist and said I need more injections. Really? I will be blind! Does anyone have any advice, please?"